Literature DB >> 11839793

Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes.

Alix Delaguillaumie1, Cécile Lagaudrière-Gesbert, Michel R Popoff, Hélène Conjeaud.   

Abstract

Activation of T lymphocytes requires the engagement of the T-cell receptor and costimulation molecules through cell-to-cell contacts. The tetraspanin CD82 has previously been shown to act as a cytoskeleton-dependent costimulation molecule. We show here that CD82 engagement leads to the tyrosine phosphorylation and association of both the Rho GTPases guanosine exchange factor Vav1 and adapter protein SLP76, suggesting that Rho GTPases participate in CD82 signaling. Indeed, broad inactivation of all Rho GTPases, or a specific blockade of RhoA, Rac1 or Cdc42, inhibited the morphological changes linked to CD82 engagement but failed to modulate the inducible association of CD82 with the actin network. Rho GTPase inactivation, as well as actin depolymerization, reduced the ability of CD82 to phosphorylate Vav and SLP76 and to potentiate the phosphorylation of two early TcR signaling intermediates: the tyrosine kinases ZAP70 and membrane adapter LAT. Taken together, this suggests that an amplification loop, via early Vav and SLP76 phosphorylations and Rho-GTPases activation, is initiated by CD82 association with the cytoskeleton, which permits cytoskeletal rearrangements and costimulatory activity. Moreover, the involvement of CD82 in the formation of the immunological synapse is strongly suggested by its accumulation at the site of TcR engagement. This novel link between a tetraspanin and the Rho GTPase cascade could explain why tetraspanins, which are known to form heterocomplexes, are involved in cell activation, adhesion, growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839793     DOI: 10.1242/jcs.115.2.433

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  28 in total

1.  Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications.

Authors:  Birgit Gellersen; Juliane Briese; Marine Oberndörfer; Katja Redlin; Annemarie Samalecos; Dagmar-Ulrike Richter; Thomas Löning; Heinrich-Maria Schulte; Ana-Maria Bamberger
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells.

Authors:  Whitney S Helms; Jerry L Jeffrey; Derek A Holmes; Michael B Townsend; Neil A Clipstone; Lishan Su
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

3.  Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Downregulation of RhoA and changes in T cell cytoskeleton correlate with the abrogation of allograft rejection.

Authors:  T Spencer Skelton; Neelam Tejpal; Yongquan Gong; Malgorzata Kloc; Rafik M Ghobrial
Journal:  Transpl Immunol       Date:  2010-07-06       Impact factor: 1.708

5.  The function of oligomerization-incompetent RDS in rods.

Authors:  Dibyendu Chakraborty; Shannon M Conley; Steven J Fliesler; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 6.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

7.  CD81 controls sustained T cell activation signaling and defines the maturation stages of cognate immunological synapses.

Authors:  V Rocha-Perugini; M Zamai; J M González-Granado; O Barreiro; E Tejera; M Yañez-Mó; V R Caiolfa; F Sanchez-Madrid
Journal:  Mol Cell Biol       Date:  2013-07-15       Impact factor: 4.272

8.  CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.

Authors:  Michela Brazzoli; Alessia Bianchi; Sara Filippini; Amy Weiner; Qing Zhu; Mariagrazia Pizza; Stefania Crotta
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Altered cell-cell and cell-matrix interactions in the development of systemic autoimmunity.

Authors:  Angelika Antoni; Lee H Graham; Joyce Rauch; Jerrold S Levine
Journal:  Autoimmunity       Date:  2009-05       Impact factor: 2.815

10.  Preferential transfer of certain plasma membrane proteins onto T and B cells by trogocytosis.

Authors:  Sandrine Daubeuf; Anne Aucher; Christine Bordier; Audrey Salles; Laurent Serre; Gérald Gaibelet; Jean-Charles Faye; Gilles Favre; Etienne Joly; Denis Hudrisier
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.